Novo Nordisk (NVO +2.09%) hopes to be the first to market with an oral version of its weight loss treatment.
*Stock prices used were the afternoon prices of Nov. 18, 2025. The video was published on Nov. 20, 2025.
Big News for Novo Nordisk Stock Investors
By Parkev Tatevosian, CFA – Nov 21, 2025 at 10:10AM EST
NYSE: NVO
Novo Nordisk
Market Cap
$186B
Today's Change
(2.09%) $1.15
Current Price
$56.26
Price as of January 6, 2026 at 4:00 PM ET
Millions of people in the world are overweight, and Novo Nordisk hopes to capture a growing share of this lucrative treatment opportunity.
Read Next
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Stocks Mentioned
Novo Nordisk
NYSE: NVO
$56.26 (+0.02%) $+1.15
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Advertisement